Cargando…
Time to shift from contemporary to high-sensitivity cardiac troponin in diagnosis of acute coronary syndromes
Early rule-in and rule-out of non-ST-segment elevation myocardial infarction (NSTEMI) is a challenge. In patients with inconclusive findings on ECG, cardiac biomarkers play a crucial role in the diagnosis. The introduction of the new high-sensitive cardiac troponin test (hs-TnI assay) has changed th...
Autores principales: | Dalal, Jamshed J., Ponde, C.K., Pinto, Brian, Srinivas, C.N., Thomas, Joy, Modi, Sunil Kumar, Mehta, Sanjay, Shetty, Suvin, Manimarane, Desai, Bhupen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143817/ https://www.ncbi.nlm.nih.gov/pubmed/27931558 http://dx.doi.org/10.1016/j.ihj.2016.03.013 |
Ejemplares similares
-
Contemporary point of care cardiac troponin testing in suspected acute coronary syndrome
por: Chapman, Andrew R, et al.
Publicado: (2019) -
Cardiac Troponins: Contemporary Biological Data and New Methods of Determination
por: Chaulin, Aleksey
Publicado: (2021) -
Important Differences Between Manufacturers When Transitioning From a Contemporary Cardiac Troponin Assay to a High-Sensitivity Cardiac Troponin Assay
por: Kavsak, Peter A., et al.
Publicado: (2021) -
S-Amlodipine: An Isomer with Difference—Time to Shift from Racemic Amlodipine
por: Dalal, Jamshed, et al.
Publicado: (2018) -
Aging and Diabetes: Shifting the Risk Trajectory With High-Sensitivity Cardiac Troponins
por: Neeland, Ian J., et al.
Publicado: (2020)